| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/25/2014 | US20140377322 Multi-layered structure for drug reservoir and drug eluting stent including the same |
| 12/25/2014 | US20140377293 Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone |
| 12/25/2014 | US20140377287 Anti-trop-2 antibody-drug conjugates and uses thereof |
| 12/25/2014 | US20140377285 Treatment regimens using multiple pharmaceutical agents |
| 12/25/2014 | US20140377278 Compositions and Methods for Assessing and Treating Inflammatory Diseases and Disorders |
| 12/25/2014 | US20140377276 Vascular endothelial cell growth factor antagonists |
| 12/25/2014 | US20140377274 Use of 2-deoxy-d-glucose to sensitize cancer cells to an agent that activates the extrinsic apoptotic pathway |
| 12/25/2014 | US20140377263 Let-7 microrna and mimetics thereof as therapeutics for cancer |
| 12/25/2014 | US20140377261 Vaccines against antigens involved in therapy resistance and methods of using same |
| 12/25/2014 | US20140377257 Combination therapy for b cell disorders |
| 12/25/2014 | US20140377252 Method for predicting the response to treatment with an her2-blocking agent |
| 12/25/2014 | US20140377247 Benzamides and related inhibitors of factor xa |
| 12/25/2014 | US20140377223 Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases |
| 12/25/2014 | US20140377219 Hiv inhibitors |
| 12/25/2014 | US20140377218 Hcv immunotherapy |
| 12/25/2014 | US20140377195 Polymer composition containing natural bioactive principles for use in pharmaceutical and cosmetic formulations |
| 12/25/2014 | US20140377175 Chemically-linked nanoparticles |
| 12/25/2014 | US20140377170 Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells |
| 12/24/2014 | CN104245720A 白细胞介素-3多肽结合物和其用途 Interleukin-3 peptide conjugates and their use |
| 12/24/2014 | CN104245702A 新型神经激肽1受体拮抗剂化合物 The new neurokinin 1 receptor antagonist compound |
| 12/24/2014 | CN104244982A 酪氨酸激酶抑制剂组合及其用途 Tyrosine kinase inhibitors and their use in combination |
| 12/24/2014 | CN104244981A Glp-1激动剂 Glp-1 agonists |
| 12/24/2014 | CN104244967A 用于抑制和治疗非自身免疫性糖尿病的Hsp60衍生肽和肽类似物 Hsp60 derived peptides for inhibition and treatment of autoimmune diabetes and non-peptide analogs |
| 12/24/2014 | CN104244965A 治疗癌症和其它病症的纳米结构 Treatment of cancer and other disorders nanostructures |
| 12/24/2014 | CN104244953A 用于治疗雄激素缺乏的联合治疗 Combination therapy for the treatment of androgen deficiency |
| 12/24/2014 | CN104232732A Mapk信号整合激酶2在治疗动脉粥样硬化中的功能和应用 Mapk signal integrity kinase 2 functions and applications in the treatment of atherosclerosis in |
| 12/24/2014 | CN104230866A C-芳基葡糖苷sglt2抑制剂和方法 C- aryl glucoside sglt2 inhibitors and methods |
| 12/24/2014 | CN104230827A 1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮作为parp抑制剂及其应用 1- (aryl-ylmethyl) quinazoline -2,4 (1h, 3h) - dione as a parp inhibitors and their Applications |
| 12/24/2014 | CN104225739A 一种医用定量吸入气雾剂 A medical MDIs |
| 12/24/2014 | CN104225621A Gadd45g基因及其表达产物在诱导肿瘤细胞衰老中的应用 Gadd45g gene and its expression products in the induction of tumor cell senescence Applications |
| 12/24/2014 | CN104225610A 与阴离子磷脂和氨基磷脂结合的选定抗体及其治疗用途 With anionic phospholipids and phospholipid binding amino selected antibodies and therapeutic uses |
| 12/24/2014 | CN104225599A 共载化疗和基因药物的非对称磁介孔二氧化硅棒及其在肿瘤诊治方面的应用 Containing a total of chemotherapy drugs and gene asymmetric magnetic mesoporous silica rod and its application in the diagnosis and treatment of cancer |
| 12/24/2014 | CN104225598A microRNA150在治疗动脉粥样硬化中的功能和应用 microRNA150 features and applications in the treatment of atherosclerosis in |
| 12/24/2014 | CN104225597A Mapk信号整合激酶1在治疗动脉粥样硬化中的功能和应用 Mapk kinase 1 signal integrated features and applications in the treatment of atherosclerosis in |
| 12/24/2014 | CN104225596A 一种治疗胃炎及胃溃疡的药物组合物 A treatment for gastritis and peptic ulcer pharmaceutical composition |
| 12/24/2014 | CN104224753A 一种包埋小分子亲水性药物缓释微囊及其制备方法 Embedding one kind of hydrophilic small molecule drug microcapsules and its preparation method |
| 12/24/2014 | CN104224720A 干粉制剂及其制备方法以及使用该制剂的干粉吸入器 A dry powder formulation and preparation method and the use of the dry powder inhaler formulation |
| 12/24/2014 | CN104224688A 负载纳米药物的丙烯酸酯化透明质酸水凝胶及其制备方法 Load acrylated hyaluronic acid hydrogel and preparation method of nano-drug |
| 12/24/2014 | CN102871996B 一种抗菌药物组合物及其应用 An antibacterial pharmaceutical compositions and applications |
| 12/24/2014 | CN102743355B 含有阿片类镇痛剂的抗篡改口服药物剂型 Anti containing opioid analgesic oral dosage form of tampering |
| 12/24/2014 | CN102643256B 一种芳基糖苷类化合物及其制备方法和应用 One aryl glycosides and its preparation method and application |
| 12/24/2014 | CN102470165B 包含胰岛素、烟酰胺和氨基酸的制剂 Formulations containing insulin, nicotinamide and amino acids |
| 12/24/2014 | CN102240040B 用于减少心血管疾病风险的油体缔合蛋白质的组合物和方法及其用途 Used in the compositions and methods for reducing the risk of cardiovascular disease associated oil body protein and use thereof |
| 12/23/2014 | US8916709 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors |
| 12/23/2014 | US8916616 Multi-functional polymeric materials and their uses |
| 12/23/2014 | US8916601 Aza-aryl 1H-pyrazol-1-YL benzene sulfonamides |
| 12/23/2014 | US8916594 5-membered ring heteroaromatic derivatives having NPY Y5 receptor antagonistic activity |
| 12/23/2014 | US8916584 Benzisoxazoles and azabenzisoxazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 12/23/2014 | US8916577 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors |
| 12/23/2014 | US8916569 Compounds and methods for inhibiting phosphate transport |
| 12/23/2014 | US8916561 Substituted quinoxaline compounds for the inhibition of PASK |
| 12/23/2014 | US8916560 Heterocyclic compounds for the inhibition of PASK |
| 12/23/2014 | US8916555 3,5-diaminopyrazole kinase inhibitors |
| 12/23/2014 | US8916554 Amino-derivatives as novel inhibitors of histone deacetylase |
| 12/23/2014 | US8916552 Pharmaceutical combinations |
| 12/23/2014 | US8916546 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress |
| 12/23/2014 | US8916545 Pharmaceutical compositions comprising POH derivatives |
| 12/23/2014 | US8916541 Synergistic combination of honokiol and modified citrus pectin in cancer therapy |
| 12/23/2014 | US8916538 Solid forms of a thiophosphoramidate nucleotide prodrug |
| 12/23/2014 | US8916536 Bone-targeting bisphosphonate duplex drugs |
| 12/23/2014 | US8916535 Use of 2′,5′-oligoadenylate derivative compounds |
| 12/23/2014 | US8916523 VIP fragments and methods of use |
| 12/23/2014 | US8916517 Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use |
| 12/23/2014 | US8916211 Method and composition for preventing and treating avian influenza in poultry |
| 12/23/2014 | US8916206 Nanoparticles containing water-soluble non-peptide low-molecular weight drug |
| 12/23/2014 | US8916194 Controlled release pharmaceutical compositions of milnacipran |
| 12/23/2014 | US8916171 Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis |
| 12/23/2014 | US8916167 Treatment and diagnosis of macrophage mediated disease |
| 12/23/2014 | US8916152 S100A4 antibodies and therapeutic uses thereof |
| 12/23/2014 | US8916146 Treatment of inflammatory diseases using placental stem cells |
| 12/18/2014 | US20140371312 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 12/18/2014 | US20140371287 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-ethylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| 12/18/2014 | US20140371259 Compounds and methods for inhibition of ap endonuclease-1/redox factor-1 (hape1) activity |
| 12/18/2014 | US20140371247 Selective and Reversible Inhibitors of Ubiquitin Specific Protease 7 |
| 12/18/2014 | US20140371243 Medical use of a dpp-4 inhibitor |
| 12/18/2014 | US20140371238 Compounds and methods for the treatment of cystic fibrosis |
| 12/18/2014 | US20140371237 p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth |
| 12/18/2014 | US20140371235 Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer |
| 12/18/2014 | US20140371233 COMPOSITIONS AND METHODS FOR TREATING Aß-MODULATED DISEASE OR DISORDER OR IMPROVING COGNITION IN A SUBJECT |
| 12/18/2014 | US20140371230 Heteroaryl derivatives as cftr modulators |
| 12/18/2014 | US20140371225 Pyridazinone compounds and methods for the treatment of cystic fibrosis |
| 12/18/2014 | US20140371219 Thieno[3,2-d]pyrimidine derivatives having inhibitory activity for protein kinases |
| 12/18/2014 | US20140371215 1-H-Pyrrolo[2,3-b]Pyridine Derivatives |
| 12/18/2014 | US20140371213 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 12/18/2014 | US20140371208 Methods of treating disease-induced ataxia and non-ataxic imbalance |
| 12/18/2014 | US20140371199 Bicyclic heterocyclic derivatives as mnk1 and mnk2 modulators and uses thereof |
| 12/18/2014 | US20140371181 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
| 12/18/2014 | US20140371179 Methods and Compositions for Treating Esophageal Diseases |
| 12/18/2014 | US20140371169 Aqueous iron carbohydrate complexes, their production and medicaments containing them |
| 12/18/2014 | US20140371158 Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway |
| 12/18/2014 | US20140371153 Method for administering omega-conopeptide |
| 12/18/2014 | US20140371150 Peptides targeting receptor activator of nuclear factor - kappa b (rank) and their applications |
| 12/18/2014 | US20140371138 Inhibitors of hepatitis c virus replication |
| 12/18/2014 | US20140371135 High purity lipopeptides |
| 12/18/2014 | US20140370121 Materials and method for inhibiting replication protein a and uses thereof |
| 12/18/2014 | US20140370118 Methods of treating malnutrition |
| 12/18/2014 | US20140370116 Method and System for Treatment of Biological Tissue |
| 12/18/2014 | US20140370105 Treatment of inflammatory bowel disease with 6-mercaptopurine |
| 12/18/2014 | US20140370089 Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy |
| 12/18/2014 | US20140370087 Novel use of angiogenin |